Insider Trading Summary for Immunovant, Inc. (IMVT): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
04-Apr-24 4:48 PM View:	02-Apr-24 Grant 0	Migausky George V Director		Immunovant, Inc. - IMVT	(1%) 122.51K to 121.06K	0	0	--	--	Show Txns Hide Txns

04-Apr-24 4:54 PM View:	02-Apr-24 Grant 0	Fromkin Drew J Director		Immunovant, Inc. - IMVT	(1%) 101.01K to 99.91K	0	0	--	--	Show Txns Hide Txns

04-Apr-24 4:50 PM View:	02-Apr-24 Grant 0	Hughes Douglas J. Director		Immunovant, Inc. - IMVT	10% 113.75K to 125.01K	0	0	--	--	Show Txns Hide Txns

04-Apr-24 4:46 PM View:	02-Apr-24 Grant 0	Pande Atul Director		Immunovant, Inc. - IMVT	(1%) 115.51K to 114.41K	0	0	--	--	Show Txns Hide Txns

19-Apr-24 5:57 PM View:	17-Apr-24 Private Sale ($990.27K)	Salzmann Peter Chief Executive Officer Director		Immunovant, Inc. - IMVT	(15%) 1.23M to 1.05M	0	0	--	--	Show Txns Hide Txns

04-Apr-24 4:44 PM View:	02-Apr-24 Grant 0	Torti Frank Director		Immunovant, Inc. - IMVT	23% 515.27K to 635.67K	0	0	--	--	Show Txns Hide Txns

19-Apr-24 6:05 PM View:	17-Apr-24 Private Sale ($240.60K)	MacIas William L. Chief Medical Officer		Immunovant, Inc. - IMVT	8% 350.15K to 377.65K	0	0	--	--	Show Txns Hide Txns

19-Apr-24 6:01 PM View:	17-Apr-24 Private Sale ($356.05K)	Barnett Eva Renee Chief Financial Officer		Immunovant, Inc. - IMVT	2% 352.59K to 359.46K	0	0	--	--	Show Txns Hide Txns

26-Apr-24 5:18 PM View:	24-Apr-24 Private Sale ($114.53K)	Levine Mark S. Chief Legal Officer		Immunovant, Inc. - IMVT	4% 330.69K to 343.16K	0	0	--	--	Show Txns Hide Txns

26-Apr-24 5:20 PM View:	24-Apr-24 Private Sale ($209.21K)	Stout Jay S Chief Technology Officer		Immunovant, Inc. - IMVT	48% 100.0K to 147.74K	0	0	--	--	Show Txns Hide Txns

19-Apr-24 5:59 PM View:	17-Apr-24 Private Sale ($293.92K)	Butchko Julia G. Chief Development Officer		Immunovant, Inc. - IMVT	5% 430.06K to 451.63K	0	0	--	--	Show Txns Hide Txns

04-Oct-23 5:15 PM View:	02-Oct-23 Purchase $58.00M	Roivant Sciences Ltd. Director 10% Owner		Immunovant, Inc. - IMVT	8% 73.81M to 79.81M	0	0	--	--	Show Txns Hide Txns

26-Apr-24 5:22 PM View:	24-Apr-24 Private Sale ($94.24K)	Geffner Michael Chief Medical Officer		Immunovant, Inc. - IMVT	42% 100.0K to 141.62K	0	0	--	--	Show Txns Hide Txns

Immunovant, Inc. (IMVT)

Last Year

03-May-23 -- 02-May-24

Company Sentiment

Other

Other

Two Year Chart

03-May-22 -- 02-May-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--